Pharmacokinetics of LY163892 in infants and children.
AUTOR(ES)
Nelson, J D
RESUMO
Two dosages (7.5 and 15 mg/kg of body weight) of LY163892 were given to infants and children, and five plasma specimens were collected for antibiotic assay during the ensuing 4 h. Peak concentrations of 12.6 and 18.7 micrograms/ml occurred at 45 min. The mean half-lives were 0.85 and 0.78 h, and the mean areas under the curve were 24.4 and 38.0 micrograms.h/ml.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=175962Documentos Relacionados
- Pharmacokinetics of cefprozil in infants and children.
- Pharmacokinetics of acyclovir suspension in infants and children.
- Pharmacokinetics of cefuroxime axetil suspension in infants and children.
- Pharmacokinetics of a clarithromycin suspension in infants and children.
- Comparative pharmacokinetics of cyclacillin and amoxicillin in infants and children.
